In a filing, Viking Therapeutics Inc revealed its Chief Operating Officer Mancini Marianna unloaded Company’s shares for reported $0.22 million on Oct 28 ’25. In the deal valued at $35.00 per share,6,185 shares were sold. As a result of this transaction, Mancini Marianna now holds 382,467 shares worth roughly $15.53 million.
Then, Rowland Charles A Jr sold 60,000 shares, generating $2,134,278 in total proceeds. Upon selling the shares at $35.57, the Director now owns 30,000 shares.
Before that, Lian Brian sold 38,989 shares. Viking Therapeutics Inc shares valued at $1,364,923 were divested by the President & CEO at a price of $35.01 per share. As a result of the transaction, Lian Brian now holds 2,419,109 shares, worth roughly $98.22 million.
Canaccord Genuity initiated its Viking Therapeutics Inc [VKTX] rating to a Buy in a research note published on October 29, 2025; the price target was $106. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Goldman began covering VKTX with “Neutral” recommendation on April 08, 2025. Scotiabank started covering the stock on February 13, 2025. It rated VKTX as “a Sector outperform”.
Price Performance Review of VKTX
On Tuesday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock jump 7.49% to $40.6. Over the last five days, the stock has gained 17.24%. Viking Therapeutics Inc shares have fallen nearly -41.03% since the year began. Nevertheless, the stocks have risen 0.89% over the past one year. While a 52-week high of $68.87 was reached on 01/06/25, a 52-week low of $18.92 was recorded on 04/09/25.
Levels Of Support And Resistance For VKTX Stock
The 24-hour chart illustrates a support level at 38.21, which if violated will result in even more drops to 35.82. On the upside, there is a resistance level at 41.84. A further resistance level may holdings at 43.08.
How much short interest is there in Viking Therapeutics Inc?
A steep rise in short interest was recorded in Viking Therapeutics Inc stocks on 2025-10-31, dropping by -3.37 million shares to a total of 24.17 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 27.54 million shares. There was a decline of -13.94%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 07, 2025 when Citigroup began covering the stock and recommended ‘”a Neutral”‘ rating along with a $38 price target.
